Pulmonary Hypertension Observational Study

Guangzhou Medical University

Status: Enrolling

Conditions: Pulmonary Hypertension

Treatments: Other: pulmonary hypertension

Study type: Observational

Funder types: Other

Identifiers

NCT05958901

Pulmonary Hypertension of GIRH

Details and patient eligibility

About

The purpose of this study is to establish the large PH cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.

Enrollment: 10,000 estimated patients

Sex: All

Ages: 20 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• PH group: When the mean pulmonary artery pressure is greater than 25mmHg at rest or greater than 30mmHg during exercise.
• Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years.

Exclusion criteria

• Acute exacerbation in the past 3 months Having other respiratory diseases with massive lung tissue destruction such as severe bronchiectasis and tuberculosis, etc.
• Serious uncontrolled diseases thoracic or abdominal surgery in the last 3 months.
• Eye surgery in the last three months.
• Retinal detachment myocardial infarction in the last 3 months.
• Admission to hospital for any cardiac condition in the last month.
• Heart rate over 120 beats per minute.
• Antibacterial chemotherapy for tuberculosis pregnant or breast feeding.

Trial design

10,000 participants in 2 patient groups

pulmonary hypertension

Treatment:

Other: pulmonary hypertension

healthy